Four Decades of Randomized Clinical Trials Influencing Mortality in Critically Ill and Perioperative Patients

URL: https://www.jcvaonline.com/article/S1053-0770(22)00227-0/fulltext

DOI: 10.1053/j.jvca.2022.04.022

Published online:Journal of Cardiothoracic and Vascular Anesthesia, April 07, 2022

Authors: Romero CS, Romero E, Maimieri N, Popp M, Marchetti C, Lombardi G, Ortalda A, Zangrillo A, Landoni G.

Article description

Summary:
  • Randomized clinical trials (RCTs) is taken as the highest level of scientific evidence
  • A review of RCTs published between January 1982 and January 2021 was performed
  • With the aim of mapping and summarizing the main characteristics and publication trends of RCTs with a statistically significant effect on mortality in critically ill and perioperative patients
  • A descriptive analysis was conducted, including general and methodologic information of all these RCTs with a statistically significant difference (p < 0.05) in mortality
  • 340 studies published in 115 journals from 42 countries were identified
  • Ventilatory support (n = 58, 17%) and hemodynamics (n = 56, 16%), were represented the most
  • 47 (14%) RCTs described a detrimental effect on survival
  • Denmark published the highest number of trials per million population
  • Female authors led 12% of RCT
  • Publishing in a high impact factor journal increased the application of the intention-to-treat principle in RCTs from 60% to 75%
Conclusions:
  • An increase in scientific production of RCTs studying, interventions that significantly influences mortality, was found
  • The main contributors of RCTs in the field during this period were the United States, China, France, Italy, and the United Kingdom, with 172 (51%)
  • 20% of studies were multinational collaborations
  • 1 in 8 RCT’s was authored by a female